Director, US Medical Research & Strategy, Diagnostics / Pathology

Join a Legacy of Innovation 125 Years and Counting! Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary The Director US Medical Affairs (USMA) Oncology, under the direction of the Senior Director, USMA Oncology (US Medical Affairs team lead for compound), is responsible for assisting with defining compound / program medical strategies and for leading select medical affairs projects within a specific compound or indication. The role is primarily responsible for US Medical Affairs Strategy and overseeing execution of medical activities for assigned indication(s) and asset(s) and will have the responsibility of managing multiple direct reports. Responsibilities - Leads the development of the US Medical Affairs strategy and execution of the US Medical Affairs plan for select indications / projects related to evidence generation, medical information and internal education, publications, scientific exchange and external data communication, and stakeholder scientific engagement. Responsible for managing budgets and resources for the assigned medical affairs plan activities, in collaboration with Sr. Director. - Leads medical readiness activities for market launches. This includes strategic partnerships with the brand team, HEOR (Health Economics and Outcomes Research), RD (Research Development), FMA (Field Medical Affairs), MIE (Medical Information and Education) and global functions as necessary to create and implement strategies that support launch. Provide medical support / input into commercial and market access discussions for select indications. - Provides medical leadership in interactions with key external stakeholders including scientific leaders, payers and societies; lead Scientific Engagement activities such as planning advisory boards, managing individual stakeholder interactions and peer to peer discussions, congress engagement activities, and collation of insights for select indications related to the compound. - Responsible for scientific communications and publications; interpretation of clinical data; ensuring consistency of clinical content and scientific statements across materials; training or communication of emerging data (internal or competitive), such as congress updates and development program highlights; and budget and forecast accuracy - In a matrix environment, represents US interests and business needs in shaping development and life cycle management strategy for select indications / projects. Reviews Externally Sponsored Research (ESRs) and may serve as deputy regional medical lead in Global IIS Review Committee meetings. May serve as medical lead for select company-sponsored evidence generating studies / projects. Manages all medical aspects such as study document development and drives execution for assigned projects in collaboration with USMA Clinical Operations and other cross-functional and regional stakeholders. Qualifications : Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation. Education Qualifications (from an accredited college or university) - An advanced doctorate degree (PharmD, Ph.D., MD, DO, or equivalent) in a medical / scientific area is required. Experience in oncology therapeutic area is required Experience Qualifications - 10 or More Years overall related experience or commensurate education / experience required - 4 or More Years experience in pharma at local, regional and / or Global level preferred - Excellent knowledge of current clinical practice in Oncology / Hematology or other relevant disease area preferred - knowledge in and understanding of medical activities (including scientific communications, medical information, MSLs, and HEOR), relating to the commercialization of oncology products preferred Travel Ability to travel up to 20% Standard office based physical demands, travel as required. Daiichi Sankyo, Inc. is an equal opportunity / affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law. Salary Range : $198,160.00 - $297,240.00Download Our Benefits Summary PDF